Expertise in
30
conditions

Dr. Richard P. Mansour

Hematology
BRFHH Shreveport LLC
1541 Kings Hwy, 
Shreveport, LA 
Accepting New Patients
Offers Telehealth
Expertise in
30
conditions
BRFHH Shreveport LLC
1541 Kings Hwy, 
Shreveport, LA 

Overview

Richard Mansour is a Hematologist practicing medicine in Shreveport, Louisiana.

Dr. Mansour is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 4 clinical trials. Dr. Mansour is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in LA

Hospital Affiliations

Ochsner Lsu Health Shreveport
Ochsner Lsu Health Shreveport-St Mary Medical Cent

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

BRFHH Shreveport LLC
1541 Kings Hwy, Shreveport, LA 71103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
Enrollment Status: Completed
Publish Date: January 13, 2026
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizuamb
Study Phase: Phase 2
View 3 Less Clinical Trials

19 Total Publications

Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma.
Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma.
Journal: Gynecologic oncology reports
Published: February 14, 2025
Similar Doctors
Expertise in
119
conditions
Dr. Anil Veluvolu
Hematology | Oncology
Expertise in
119
conditions
Dr. Anil Veluvolu
Hematology | Oncology
Referral may be required

Willis Knighton Hematology/Oncology North

2600 Kings Hwy Ste 300, 
Shreveport, LA 
 (0.9 miles away)
318-333-6270
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anil Veluvolu is a Hematologist and an Oncologist practicing medicine in Shreveport, Louisiana. Dr. Veluvolu is highly rated in 119 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Colorectal Cancer, Lynch Syndrome, and Liver Embolization. Dr. Veluvolu is currently accepting new patients.

Expertise in
51
conditions
Dr. Sakeer Hussain
Hematology | Oncology
Expertise in
51
conditions
Dr. Sakeer Hussain
Hematology | Oncology
Referral may be required

Lsuhsc Shreveport

1501 Kings Hwy, 
Shreveport, LA 
 (0.1 miles away)
318-813-1057
Languages Spoken:
English, Burmese, Hindi, Malay, Malayalam
See accepted insurances
Accepting New Patients
Offers Telehealth

Sakeer Hussain is a Hematologist and an Oncologist practicing medicine in Shreveport, Louisiana. Dr. Hussain is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Chronic Familial Neutropenia, Paget Disease of the Breast, Colorectal Cancer, and Lynch Syndrome. Dr. Hussain is currently accepting new patients.

Expertise in
32
conditions
Expertise in
32
conditions
Referral may be required

Lsuhsc Shreveport

1501 Kings Hwy, 
Shreveport, LA 
 (0.1 miles away)
318-813-2528
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samip Master is a Hematologist practicing medicine in Shreveport, Louisiana. Dr. Master is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Master is currently accepting new patients.

Frequently Asked Questions about Dr. Richard P. Mansour

How do I make an appointment with Dr. Richard P. Mansour?

You can book an appointment with Dr. Richard P. Mansour by calling their office at 318-675-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard P. Mansour a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard P. Mansour is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard P. Mansour specialize in?

While Dr. Richard P. Mansour is a Hematology, they have specific expertise in Sickle Cell Disease, Hemoglobin SC Disease, and Chronic Lymphocytic Leukemia (CLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Richard P. Mansour participate in research or clinical trials?

Yes. Dr. Richard P. Mansour has published 19 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Richard P. Mansour's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard P. Mansour accept my insurance?

Dr. Richard P. Mansour accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 318-675-5000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mansour's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile